Doctor of Philosophy in Experimental Medicine (PhD)
Identification of blood-based biomarkers to distinguish subtypes of interstitial lung disease
Fibrotic interstitial lung diseases (ILDs) are characterized by inflammation and fibrosis of the pulmonary parenchyma. In addition to the primary symptoms of dyspnea and cough, many patients with fibrotic ILD experience extrapulmonary deficits that can interfere with their ability to stay active. This is a concern as the maintenance of physical activity plays an important part in independence and prevention of deconditioning in patients with fibrotic ILD. However, the impact of common extrapulmonary deficits on daily physical activity of these patients is not known.Accordingly, in chapter 2, we examined the impact of depression, anxiety, poor sleep quality, and pain on daily physical activity in a cohort of 111 patients with fibrotic ILD. Extrapulmonary deficits were assessed using the Hospital Anxiety and Depression Scale, the Pittsburgh Sleep Quality Index, and the Brief Pain Inventory short form. Patients' physical activity was monitored for seven consecutive days using waist and wrist tri-axial accelerometers, in addition to the self-reported International Physical Activity Questionnaire long form (IPAQ-LF). Although depression and pain were moderately associated with lower step count on unadjusted analysis, extrapulmonary deficits did not independently predict lower physical activity when adjusting for basic demographics and ILD severity. However, we identified higher pain severity to be an independent predictor of lower step count using a multivariable stepwise approach. This finding suggests that pain may be a potential area that could be targeted by interventions to help patients maintain physical activity.In chapter 3, we examined the validity of the IPAQ-LF and estimated the minimally important difference (MID) for moderate-to-vigorous physical activity (MVPA) in patients with fibrotic ILD. We found the IPAQ-LF to have acceptable validity based on its measurements having moderate-to-strong correlations with corresponding waist accelerometer data and relevant clinical outcomes. The MID for weekly MVPA was estimated to be less than 60 minutes/week using the anchor-based approach. This indicates that adding only 60 minutes of MVPA per week is a realistic goal that brings meaningful benefits to patients with fibrotic ILD and provides a goal threshold for future clinical trials.